| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case for Risk-adapted Management of Low-grade Bladder Tumors
|
Soloway, Mark
|
|
|
|
1 |
p. 128-129
|
artikel
|
| 2 |
A Case Series of Preoperative Endovascular Stenting in Patients Undergoing Postchemotherapy Resection of Complex Oncologic Masses
|
Amend, Gregory
|
|
|
|
1 |
p. 1-6
|
artikel
|
| 3 |
Active Surveillance Doing Well Under Surveillance
|
Ellen, O’Connor
|
|
|
|
1 |
p. 92-93
|
artikel
|
| 4 |
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative
|
Kalapara, Arveen A.
|
|
|
|
1 |
p. 80-91
|
artikel
|
| 5 |
Analysis of Magnetic Resonance Imaging–directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis
|
Schoots, Ivo G.
|
|
|
|
1 |
p. 32-41
|
artikel
|
| 6 |
A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria—A Prospective Multicentre Performance Evaluation of ADXBLADDER
|
Dudderidge, Tim
|
|
|
|
1 |
p. 42-46
|
artikel
|
| 7 |
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer
|
Stabile, Armando
|
|
|
|
1 |
p. 29-36
|
artikel
|
| 8 |
A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer
|
De Visschere, Pieter J.L.
|
|
|
|
1 |
p. 47-76
|
artikel
|
| 9 |
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11
|
Reza, Mariana
|
|
|
|
1 |
p. 49-55
|
artikel
|
| 10 |
Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours
|
Mostafid, Hugh
|
|
|
|
1 |
p. 12-19
|
artikel
|
| 11 |
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard
|
Stabile, Armando
|
|
|
|
1 |
p. 1-17
|
artikel
|
| 12 |
Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic
|
Qian, Zhiyu
|
|
|
|
1 |
p. 151-154
|
artikel
|
| 13 |
Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy
|
Fasulo, Vittorio
|
|
|
|
1 |
p. 61-69
|
artikel
|
| 14 |
Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review
|
Crupi, Emanuele
|
|
|
|
1 |
p. 44-52
|
artikel
|
| 15 |
Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer
|
Loeb, Stacy
|
|
|
|
1 |
p. 1-9
|
artikel
|
| 16 |
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer
|
Kates, Max
|
|
|
|
1 |
p. 117-120
|
artikel
|
| 17 |
Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies
|
Solanki, Abhishek A.
|
|
|
|
1 |
p. 79-87
|
artikel
|
| 18 |
Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration
|
Vander Velde, Nancy
|
|
|
|
1 |
p. 12-20
|
artikel
|
| 19 |
Comprehensive Management of Renal Masses in Solitary Kidneys
|
Yasuda, Yosuke
|
|
|
|
1 |
p. 84-94
|
artikel
|
| 20 |
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis
|
Goel, Shokhi
|
|
|
|
1 |
p. 10-20
|
artikel
|
| 21 |
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration
|
Bandini, Marco
|
|
|
|
1 |
p. 121-123
|
artikel
|
| 22 |
Contents
|
|
|
|
|
1 |
p. iii-v
|
artikel
|
| 23 |
Contents
|
|
|
|
|
1 |
p. iii-iv
|
artikel
|
| 24 |
Contents
|
|
|
|
|
1 |
p. iii-iv
|
artikel
|
| 25 |
Contents
|
|
|
|
|
1 |
p. iii-iv
|
artikel
|
| 26 |
Contents
|
|
|
|
|
1 |
p. iii-v
|
artikel
|
| 27 |
Contents
|
|
|
|
|
1 |
p. iii-v
|
artikel
|
| 28 |
Contents
|
|
|
|
|
1 |
p. iii-v
|
artikel
|
| 29 |
Current Management of pT3b Prostate Cancer After Robot-assisted Laparoscopic Prostatectomy
|
Poelaert, Filip
|
|
|
|
1 |
p. 110-117
|
artikel
|
| 30 |
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases
|
Heidenreich, Axel
|
|
|
|
1 |
p. 46-53
|
artikel
|
| 31 |
Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non–muscle-invasive Bladder Cancer
|
Jobczyk, Mateusz
|
|
|
|
1 |
p. 109-112
|
artikel
|
| 32 |
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer
|
Martini, Alberto
|
|
|
|
1 |
p. 42-48
|
artikel
|
| 33 |
Defining the Role of Large Language Models in Urologic Care and Research
|
Gupta, Raghav
|
|
|
|
1 |
p. 1-13
|
artikel
|
| 34 |
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial
|
Saner, Yasemin Melisa
|
|
|
|
1 |
p. 49-55
|
artikel
|
| 35 |
Development and Internal Validation of a Nomogram for Predicting Renal Function after Partial Nephrectomy
|
Bertolo, Riccardo
|
|
|
|
1 |
p. 106-109
|
artikel
|
| 36 |
Development of a Personalized Chat Model Based on the European Association of Urology Oncology Guidelines: Harnessing the Power of Generative Artificial Intelligence in Clinical Practice
|
Khene, Zine-Eddine
|
|
|
|
1 |
p. 160-162
|
artikel
|
| 37 |
Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma
|
Voskuilen, Charlotte S.
|
|
|
|
1 |
p. 73-79
|
artikel
|
| 38 |
Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology
|
Arita, Yuki
|
|
|
|
1 |
p. 99-102
|
artikel
|
| 39 |
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
|
Rescigno, Pasquale
|
|
|
|
1 |
p. 71-77
|
artikel
|
| 40 |
Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the “Real World”? A Systematic Review
|
Dodkins, Joanna
|
|
|
|
1 |
p. 14-24
|
artikel
|
| 41 |
Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer
|
Grassauer, Jacob
|
|
|
|
1 |
p. 139-146
|
artikel
|
| 42 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 43 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 44 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 45 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 46 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 47 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 48 |
Editorial Board
|
|
|
|
|
1 |
p. i-ii
|
artikel
|
| 49 |
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA
|
Hanna, Nawar
|
|
|
|
1 |
p. 83-90
|
artikel
|
| 50 |
Efficacy and Effectiveness: Bridging the Gap Between Clinical Trials and Real-world Practice
|
Nguyen, David-Dan
|
|
|
|
1 |
p. 25-26
|
artikel
|
| 51 |
Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database
|
Moschini, Marco
|
|
|
|
1 |
p. 94-101
|
artikel
|
| 52 |
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
|
Efstathiou, Eleni
|
|
|
|
1 |
p. 119-127
|
artikel
|
| 53 |
Erratum to ‘Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations’[European Urology Oncology 2 (2019) 277-285]
|
Gandellini, Paolo
|
|
|
|
1 |
p. 129
|
artikel
|
| 54 |
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer
|
Goldberg, Hanan
|
|
|
|
1 |
p. 88-96
|
artikel
|
| 55 |
Facts and Myths About Stage Migration: Should the Will Rogers Phenomenon Ride off into the Distance?
|
Fanti, Stefano
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 56 |
Features and Prognostic Significance of Intraductal Carcinoma of the Prostate
|
Montironi, Rodolfo
|
|
|
|
1 |
p. 21-28
|
artikel
|
| 57 |
First-in-human Evaluation of a Prostate-specific Membrane Antigen–targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy
|
Nguyen, Hao G.
|
|
|
|
1 |
p. 63-72
|
artikel
|
| 58 |
Frailty and Greater Health Care Resource Utilization Following Major Urologic Oncology Surgery
|
Taylor, Benjamin L.
|
|
|
|
1 |
p. 21-27
|
artikel
|
| 59 |
Gender Disparity in Cystectomy Postoperative Outcomes: Propensity Score Analysis of the National Surgical Quality Improvement Program Database
|
Bukavina, Laura
|
|
|
|
1 |
p. 84-92
|
artikel
|
| 60 |
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder Cancer
|
Galesloot, Tessel E.
|
|
|
|
1 |
p. 70-83
|
artikel
|
| 61 |
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer
|
Parry, Marina A.
|
|
|
|
1 |
p. 1-11
|
artikel
|
| 62 |
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer
|
Aggarwal, Rahul
|
|
|
|
1 |
p. 78-82
|
artikel
|
| 63 |
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA
|
Ward, Douglas G.
|
|
|
|
1 |
p. 67-75
|
artikel
|
| 64 |
High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers
|
Beulens, Alexander J.W.
|
|
|
|
1 |
p. 39-46
|
artikel
|
| 65 |
Hyperthermic Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
|
Angulo, Javier C.
|
|
|
|
1 |
p. 58-66
|
artikel
|
| 66 |
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
|
Ma, Ting Martin
|
|
|
|
1 |
p. 100-103
|
artikel
|
| 67 |
Improving the Quality of Transurethral Resection of Bladder Tumor: Urologist, Audit Thyself
|
Herr, Harry
|
|
|
|
1 |
p. 20-21
|
artikel
|
| 68 |
Intermediate-risk Prostate Cancer—A Sheep in Wolf’s Clothing?
|
Heidegger, Isabel
|
|
|
|
1 |
p. 103-109
|
artikel
|
| 69 |
International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma
|
Lyon, Timothy D.
|
|
|
|
1 |
p. 76-83
|
artikel
|
| 70 |
Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes
|
Larcher, Alessandro
|
|
|
|
1 |
p. 61-68
|
artikel
|
| 71 |
Large Language Models in Uro-oncology
|
Ferber, Dyke
|
|
|
|
1 |
p. 157-159
|
artikel
|
| 72 |
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non–muscle-invasive Bladder Cancer
|
Nicolazzo, Chiara
|
|
|
|
1 |
p. 124-125
|
artikel
|
| 73 |
Locally Advanced Kidney Cancer: A New Space for Immunotherapy?
|
Singla, Nirmish
|
|
|
|
1 |
p. 118-119
|
artikel
|
| 74 |
Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review
|
Thompson, Daryl
|
|
|
|
1 |
p. 4-15
|
artikel
|
| 75 |
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
|
Dahl, Douglas M.
|
|
|
|
1 |
p. 83-90
|
artikel
|
| 76 |
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
|
Fernández-Pello, Sergio
|
|
|
|
1 |
p. 57-72
|
artikel
|
| 77 |
Metastases-directed Therapies in the Prostate-specific Membrane Antigen Era: Not All That Glitters Is Curable
|
Gandaglia, Giorgio
|
|
|
|
1 |
p. 52-53
|
artikel
|
| 78 |
Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature
|
Nallandhighal, Srinivas
|
|
|
|
1 |
p. 92-99
|
artikel
|
| 79 |
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence
|
Bianchi, Lorenzo
|
|
|
|
1 |
p. 41-48
|
artikel
|
| 80 |
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial
|
Anari, Fern
|
|
|
|
1 |
p. 54-60
|
artikel
|
| 81 |
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
|
Gorin, Michael A.
|
|
|
|
1 |
p. 113-117
|
artikel
|
| 82 |
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature
|
Campi, Riccardo
|
|
|
|
1 |
p. 22-41
|
artikel
|
| 83 |
On Being Sick and Tired
|
Montorsi, Francesco
|
|
|
|
1 |
p. 7-9
|
artikel
|
| 84 |
Optimizing Imperfect Patient Management Recommendations Post-prostatectomy
|
Roach 3rd, Mack
|
|
|
|
1 |
p. 19-20
|
artikel
|
| 85 |
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer
|
Kishan, Amar U.
|
|
|
|
1 |
p. 3-18
|
artikel
|
| 86 |
Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors
|
Graham, Jeffrey
|
|
|
|
1 |
p. 102-111
|
artikel
|
| 87 |
Parenchymal Mass Preserved after Partial Nephrectomy and “Global Renal Damage”: Two Faces of the Same Coin
|
Porpiglia, Francesco
|
|
|
|
1 |
p. 104-105
|
artikel
|
| 88 |
Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices
|
van Stam, Marie-Anne
|
|
|
|
1 |
p. 21-31
|
artikel
|
| 89 |
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
|
Laukhtina, Ekaterina
|
|
|
|
1 |
p. 120-124
|
artikel
|
| 90 |
Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial
|
Neuberger, Manuel
|
|
|
|
1 |
p. 53-62
|
artikel
|
| 91 |
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-up
|
Stopsack, Konrad H.
|
|
|
|
1 |
p. 110-112
|
artikel
|
| 92 |
Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer
|
Wang, Ying
|
|
|
|
1 |
p. 56-65
|
artikel
|
| 93 |
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy
|
Wu, Zhenjie
|
|
|
|
1 |
p. 112-121
|
artikel
|
| 94 |
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
|
Eckstein, Markus
|
|
|
|
1 |
p. 128-138
|
artikel
|
| 95 |
Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer
|
Pecoraro, Martina
|
|
|
|
1 |
p. 73-82
|
artikel
|
| 96 |
Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel
|
Mahal, Brandon A.
|
|
|
|
1 |
p. 18-29
|
artikel
|
| 97 |
Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Göteborg Prostate Cancer Screening 2 Trial
|
Wallström, Jonas
|
|
|
|
1 |
p. 54-60
|
artikel
|
| 98 |
Prostate-specific Membrane Antigen–radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases
|
Lunger, Lukas
|
|
|
|
1 |
p. 95-98
|
artikel
|
| 99 |
PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy
|
Schiller, Kilian
|
|
|
|
1 |
p. 73-83
|
artikel
|
| 100 |
Putting Prostate Cancer Metabolism into the Right Context
|
Mills, Ian G.
|
|
|
|
1 |
p. 37-38
|
artikel
|
| 101 |
Randomized Controlled Feasibility Trial of Robot-assisted Versus Conventional Open Partial Nephrectomy: The ROBOCOP II Study
|
Kowalewski, Karl-Friedrich
|
|
|
|
1 |
p. 91-97
|
artikel
|
| 102 |
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
|
Santoni, Matteo
|
|
|
|
1 |
p. 102-111
|
artikel
|
| 103 |
Re: Bradley McGregor, Daniel M. Geynisman, Mauricio Burotto, et al. A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023;6:339–348
|
Chadha, Juskaran
|
|
|
|
1 |
p. 172
|
artikel
|
| 104 |
Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428–35
|
Falagario, Ugo Giovanni
|
|
|
|
1 |
p. 167-168
|
artikel
|
| 105 |
Re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging After Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629–634
|
Abreu-Gomez, Jorge
|
|
|
|
1 |
p. 169-170
|
artikel
|
| 106 |
Re: Freddie C. Hamdy, Jennie L. Donovan, J. Athene Lane, et al. Fifteen-year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547–58
|
Campodonico, Fabio
|
|
|
|
1 |
p. 171
|
artikel
|
| 107 |
Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging–targeted Biopsy. Eur Urol Oncol 2020;7:739–47
|
Morka, Naomi
|
|
|
|
1 |
p. 127-128
|
artikel
|
| 108 |
Re: Hugh Mostafid, Ashish M. Kamat, Siamak Daneshmand, et al. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. Eur Urol Oncol 2021;4:12–9
|
Montorsi, Francesco
|
|
|
|
1 |
p. 126
|
artikel
|
| 109 |
Reply to Ugo Giovanni Falagario, Alberto Martini, Francesco Pellegrino, et al.’s Letter to the Editor re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428–35
|
Tilki, Derya
|
|
|
|
1 |
p. 166
|
artikel
|
| 110 |
Reply to Wen-Wei Sung’s Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531–534
|
Tan, Wei Shen
|
|
|
|
1 |
p. 164-165
|
artikel
|
| 111 |
Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)
|
Heidenreich, Axel
|
|
|
|
1 |
p. 122-127
|
artikel
|
| 112 |
Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers
|
Huynh, Mai Anh
|
|
|
|
1 |
p. 28-38
|
artikel
|
| 113 |
Re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531–534
|
Sung, Wen-Wei
|
|
|
|
1 |
p. 163
|
artikel
|
| 114 |
Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy
|
Tully, Karl H.
|
|
|
|
1 |
p. 66-72
|
artikel
|
| 115 |
Robot-assisted Versus Open Partial Nephrectomy: Do We Really Need More Evidence To End the Debate?
|
Peyronnet, Benoit
|
|
|
|
1 |
p. 69-70
|
artikel
|
| 116 |
Robotic Versus Open Partial Nephrectomy: From the “Shadows” of Randomized Controlled Trials to the “Reality” of Value-based Care for Patients with Localized Renal Masses
|
Campi, Riccardo
|
|
|
|
1 |
p. 98-101
|
artikel
|
| 117 |
Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer—A Systematic Review
|
de Barros, Hilda A.
|
|
|
|
1 |
p. 16-27
|
artikel
|
| 118 |
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study
|
Bergengren, Oskar
|
|
|
|
1 |
p. 37-45
|
artikel
|
| 119 |
Stereotactic Body Radiotherapy for Oligometastatic and Oligoprogressive Genitourinary Malignancies: A Work in Progress
|
Horsley, Patrick J.
|
|
|
|
1 |
p. 39-40
|
artikel
|
| 120 |
Stereotactic Magnetic Resonance–guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort
|
Yim, Kendrick
|
|
|
|
1 |
p. 147-150
|
artikel
|
| 121 |
Streamlining Germline Genetic Testing in Prostate Cancer
|
McKay, Rana R.
|
|
|
|
1 |
p. 10-11
|
artikel
|
| 122 |
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy
|
DiNatale, Renzo G.
|
|
|
|
1 |
p. 47-56
|
artikel
|
| 123 |
The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature
|
Sood, Akshay
|
|
|
|
1 |
p. 27-43
|
artikel
|
| 124 |
The Impact of Surgical Strategy in Robot-assisted Partial Nephrectomy: Is It Beneficial to Treat Anterior Tumours with Transperitoneal Access and Posterior Tumours with Retroperitoneal Access?
|
Dell’Oglio, Paolo
|
|
|
|
1 |
p. 112-116
|
artikel
|
| 125 |
The Metabolic Landscape of Prostate Cancer
|
Giunchi, Francesca
|
|
|
|
1 |
p. 28-36
|
artikel
|
| 126 |
The Optimal Prostate Biopsy in the Era of Multiparametric Magnetic Resonance Imaging
|
Smigelski, Michael
|
|
|
|
1 |
p. 56-57
|
artikel
|
| 127 |
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies
|
Dell’Oglio, Paolo
|
|
|
|
1 |
p. 112-118
|
artikel
|
| 128 |
The Rising Star for Early Recurrent Cancer is Modern Imaging. But is it a Real Game Changer?
|
Salomon , Georg
|
|
|
|
1 |
p. 77-78
|
artikel
|
| 129 |
The Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial
|
Lim, Amy H.
|
|
|
|
1 |
p. 102-103
|
artikel
|
| 130 |
Three-dimensional Virtual Models’ Assistance During Minimally Invasive Partial Nephrectomy Minimizes the Impairment of Kidney Function
|
Amparore, Daniele
|
|
|
|
1 |
p. 104-108
|
artikel
|
| 131 |
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography–staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial
|
Hölscher, Tobias
|
|
|
|
1 |
p. 44-51
|
artikel
|
| 132 |
Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer
|
Joshi, Shreyas S.
|
|
|
|
1 |
p. 104-111
|
artikel
|
| 133 |
Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future Insights
|
Benamran, Daniel
|
|
|
|
1 |
p. 125-133
|
artikel
|
| 134 |
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin
|
Lobo, Niyati
|
|
|
|
1 |
p. 84-91
|
artikel
|
| 135 |
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors
|
Lonati, Chiara
|
|
|
|
1 |
p. 30-41
|
artikel
|
| 136 |
Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening
|
Grobet-Jeandin, Elisabeth
|
|
|
|
1 |
p. 42-43
|
artikel
|
| 137 |
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria
|
Valenberg, Franciscus Johannes P. van
|
|
|
|
1 |
p. 93-101
|
artikel
|
| 138 |
Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors
|
Wu, Jitao
|
|
|
|
1 |
p. 97-103
|
artikel
|
| 139 |
Welcome to European Urology Oncology: Your New Journal, Where Multiple Disciplines Meet To Improve Care of Patients with Genitourinary Cancers
|
Briganti, Alberto
|
|
|
|
1 |
p. 1-2
|
artikel
|
| 140 |
Would Uro_Chat, a Newly Developed Generative Artificial Intelligence Large Language Model, Have Successfully Passed the In-Service Assessment Questions of the European Board of Urology in 2022?
|
May, Matthias
|
|
|
|
1 |
p. 155-156
|
artikel
|
Tijdschrift beschrijving